MedPath

Comparison of an Interscalene Nerve Block With or Without Stellate Ganglion Block for Shoulder Surgery

Phase 4
Completed
Conditions
Anesthesia, Regional
Interventions
Drug: NaCl 0.9%
Drug: Levobupivacaine
Registration Number
NCT02879916
Lead Sponsor
University Hospital, Antwerp
Brief Summary

This study describes the difference of analgesic effect of levobupivacaine 0.5% administered through an interscalene nerve block with or without a stellate ganglion block. The length of the analgesic effect is our primary outcome parameter. Half of the recruited patients will receive a stellate ganglion block and half of the patients won't.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • ASA class 1 to 3
  • Need for shoulder surgery
Read More
Exclusion Criteria
  • Mental retardation
  • allergy for local anesthetics
  • a medical reason as a contra-indication for NSAID use
  • Diabetes mellitus
  • peripheral neuropathy
  • chronic analgetic use
  • chronic pain patients
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboNaCl 0.9%NaCl 0.9% 3ml perineural stellate ganglion injection
Stellate ganglion blockLevobupivacaineLevobupivacaine 3ml perineural stellate ganglion injection
Primary Outcome Measures
NameTimeMethod
Duration of analgesia24 hours

The duration of analgesia assessed with quantitative sensory testing

Secondary Outcome Measures
NameTimeMethod
Need for rescue analgesia24 hours

The timing of the need for rescue analgesia as requested by the patient

Duration of motor block24 hours

The duration of a motor block

© Copyright 2025. All Rights Reserved by MedPath